ADDF | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

993 results for “ADDF”

Trials

View all 882 →

Eardream Data Collection in Colombia Supported by ADDF

120 participants · First posted Oct 6, 2022

Eardream Data Collection in Switzerland Supported by ADDF

120 participants · First posted Apr 11, 2022

Troponin I Release After High Diuretic Doses

60 participants · First posted Aug 17, 2011

Drugs

View all 24 →

ADNF-14

ADD-17014

ADD-196022

Organizations

Psychogenics, Inc.

United States

Theragnostics Ltd.

United Kingdom

Infectious Disease Research Institute

United States

News

View all 83 →

FDA to Convene Advisory Committee for Eli Lilly's Alzheimer's Drug Donanemab

MindImmune Secures $5 Million ADDF Investment to Advance First-in-Class Alzheimer's Immunotherapy MITI-101

ADDF Invests $2.16 Million in Life Molecular Imaging's Novel PET Tracer for Alzheimer's Neuroinflammation

Page 1 of 100